News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

BioSpace News - All
What You Need to Know About Oncorus 1/20/2017
What You Need to Know About Decibel Therapeutics 1/20/2017
McKesson Pharma (MCK) to Pink Slip Some Employees in Wisconsin, Effective March 31 1/20/2017
NIH Director to Keep Job Under Trump, for Now 1/20/2017
Theranos' Last Defender Claims Federal Witch Hunt 1/20/2017
Who Might or Might Not Buy Regeneron (REGN), And Why 1/20/2017
A Peek Behind the Curtain of the Ariad (ARIA)-Takeda (TKPYY) Deal 1/20/2017
New FDA Report Cites 22 Drugs That Passed Phase II But Crashed and Burned in Phase III 1/20/2017
GlaxoSmithKline (GSK) Poaches AstraZeneca PLC (AZN) Exec to Replace Exiting Pharma Head 1/19/2017
Not So Different After All: 5 Overlapping Skills Needed in Life Science Academia vs. Industry 1/19/2017
5 Biotechs and the Drugs That May Put Them in Trump's Disfavor 1/19/2017
Merck & Co. (MRK) Expands Discovery to New South San Francisco Facility in Heart of Bay Area and Looks to Hire 100 Employees 1/19/2017
Struggling MannKind (MNKD)'s New Strategy Includes Doubling Its Sales Force 1/19/2017
Calling All Scientists: 7 Things You Need to Know About Paid Biotech Internships 1/19/2017
9 Tips to Create the Best Clinical Research Resume or CV 1/19/2017
Anonymous Short Trader Attacks Cellceutix (CTIX) Again 1/19/2017
What You Need to Know About Ideaya 1/19/2017
What You Need to Know About Morphic Therapeutic 1/19/2017
Sanofi (SNY) Exec Jumps Ship to Helm Merrimack (MACK) 1/19/2017
485 Eli Lilly (LLY) Employees Will be Out of Work Beginning March 31 1/19/2017
What Trump and His Potential Nominees Should Understand About the FDA 1/19/2017
Massachusetts' CoLucid Pharma (CLCD) Surges on $960 Million Eli Lilly (LLY) Buyout Deal 1/19/2017
Martin Shkreli's Complaint Leads to a $100 Million FTC Settlement for This Biotech 1/19/2017
Theranos Shuts Down Last Remaining Blood-Testing Lab After Another Failed Inspection 1/19/2017
Pfizer (PFE) CEO: What Trump Doesn't Understand About Pharma 1/19/2017
PAGXXV: Science, Crop Diseases and GMO Controversy 1/18/2017
What You Need to Know About Adicet Bio 1/18/2017
What You Need to Know About Codiak BioSciences 1/18/2017
2017 Could be The Breakout Year for These 5 Biotechs 1/18/2017
Embattled Theranos Forms New Advisory Board of Biotech Experts 1/18/2017
Battered Ophthotech (OPHT) Cuts 80% of Staff After Failed Clinical Trials 1/18/2017
ImmunoGen (IMGN) CEO Sees Potential in Company’s Lead ADC Product 1/18/2017
Meet the 27-Year Old CEO Who's Running Biotech Visikol 1/18/2017
Tiny Ovid Inks a Unique Rare Disease Deal With Drug Giant Takeda (TKPYY) 1/18/2017
Why Bristol-Myers Squibb (BMY) Could be a Takeover Target Soon 1/18/2017
Why the Government Should Pay $156 Billion to Own Gilead (GILD) 1/18/2017
Tiny Forward Pharma (FWP) Rockets on $1.25 Billion Cash Deal With Biogen (BIIB) 1/18/2017
New Grunenthal CEO Forges Ahead with Treatment for Complex Regional Pain Syndrome 1/18/2017
Time to Get on the Train: 3 Biotechs That are About to Have Its Breakout Moment 1/18/2017
Silicon Valley Exec Meets Trump for FDA Job 1/17/2017
Genentech (RHHBY) Dealt a Blow From Massachusetts' Highest Court 1/17/2017
What You Need to Know About Tioma Therapeutics 1/17/2017
What You Need to Know About Blade Therapeutics 1/17/2017
Google (GOOG)'s Verily Pumps 1.4 Billion Euros Into Ireland; Expansion to Create 400 New Jobs 1/17/2017
NantKwest CEO (AKA World's Richest Doctor) Rumored to Have Met Trump for Top NIH Job 1/17/2017
Struggling OvaScience (OVAS) Offers CFO Cash to Stay on Board 1/17/2017
Newly Created Fibrocor Therapeutics Makes Debut 1/17/2017
MiMedx CEO Allegedly Demanded Employees Donate Cash to Support GOP Candidates Like Tom Price 1/17/2017
New Spinraza Data Has Biogen (BIIB) Screaming 'It's Worth It!' 1/16/2017
Trump's HHS Nominee and His Ties With Two Massachusetts Biotech Firms 1/16/2017
JPM17: Surprise! Pfizer (PFE) is Still Deal Hungry for M&As After Medivation (MDVN) 1/16/2017
What You Need to Know About GRAIL 1/16/2017
What You Need to Know About Petra Pharma 1/16/2017
Here's a Look at Allergan (AGN)'s Opportunity in NASH 1/16/2017
PAGXXV in San Diego: A Study in Cross-Pollination 1/16/2017
JPM17: Why the Key to Gene Therapy Could be in an Old Bay Area Warehouse 1/16/2017
Struggling Nivalis (NVLS) Cuts 80% of Staff, Including CEO and CMO 1/13/2017
And It Gets Worse...Arizona Planning to Sue Theranos Over Faulty Blood Tests 1/13/2017
What You Need to Know About Forty Seven 1/13/2017
Gilead (GILD): To Split or Not to Split... 1/13/2017
What You Need to Know About Semma Therapeutics 1/13/2017
JPM17: Opko Health (OPK) CEO's Gameplan After Its Recent Growth Hormone Failure 1/13/2017
Trump Says Pharma Getting Away With Murder, Vows to Lower Drug Prices 1/13/2017
Tesaro (TSRO) Craters as the FDA Denies Approval of Rolapitant IV 1/13/2017
Meet AstraZeneca PLC (AZN)'s New Head of Oncology 1/13/2017
3 Little-Known Drugmakers That Deserve More Attention 1/13/2017
Takeda (TKPYY) Takes a $125 Million+ Chance, Seals an Option to Buy Bay Area Startup Maverick Therapeutics 1/12/2017
Florida-Based Wearable Device Maker ActiGraph Surges Into 2017 With Big Data Sleep Tech 1/12/2017
After Ariad (ARIA), These 3 Drug Cancer Firms Could be Taken Out Next 1/12/2017
JPM17: Biotech IPO Guru Vivek Ramaswamy Expects More Startups, Deals in 2017 1/12/2017
Merck KGaA (MKGAF.PK) Lays Off Some Employees in Shutdown of Its Massachusetts Accounting Office 1/12/2017
What You Need to Know About Neon Therapeutics 1/12/2017
Trump Has Another Top FDA Post to Fill 1/12/2017
What You Need to Know About Denali 1/12/2017
JPM17: New Biogen (BIIB) CEO on Groundbreaking Alzheimer's Trial and the Company's Future 1/12/2017
What You Need to Know About Arcus Biosciences 1/12/2017
Cosmetic Giant L'Oreal Pays $1.3 Billion for Three Skincare Brands From Valeant (VRX) 1/11/2017
JPM17: Sarepta (SRPT)'s New Numbers Impress Investors, Stock Gained $300 Million Overnight 1/11/2017
What You Need to Know About C4 Therapeutics 1/11/2017
JPM17: How Celgene (CELG) Wowed Yet Again 1/11/2017
JPM17: Secretive Moderna Finally Unveils Pipeline, Financials 1/11/2017
Daiichi Sankyo to Shutter Indian R&D Center, 170 Employees Affected 1/11/2017
JPM17: Eli Lilly (LLY) Not Looking for a Mega-Merger But Stays Open to Other M&A Deals 1/11/2017
JPM17: Aurinia (AUPH)’s CEO on a Mission to Improve the Way Lupus Nephritis is Treated 1/11/2017
Debt-Ridden Valeant (VRX) Offloads Dendreon (DNDN) for $819.9 Million Cash 1/11/2017
On a Roll: Kite Pharma (KITE) Bags $250 Million CAR-T Deal From Daiichi Sankyo, Forms Joint Venture With Fosun Pharma 1/11/2017
This German Biotech Just Inked a $1 Billion+ Cancer Deal With Biotech Giant Amgen (AMGN) 1/10/2017
Takeda (TKPYY) Swallows Up Struggling Ariad (ARIA) in $5.2 Billion Deal 1/10/2017
How Ariad (ARIA)'s Price Hikes Resulted in a $5 Billion Payday for Investors 1/10/2017
Cambridge's Merrimack (MACK) Slashes 80% of Workforce, Sells Off Cancer Drugs in $1.025 Billion Deal 1/10/2017
JPM17: Vertex (VRTX) Game Plan for Growth in 2017 1/10/2017
Pharma Bro Martin Shkreli's Twitter Account Suspended After Harassing Journalist 1/10/2017
Finding a Complementary Secondary Endpoint in Lupus Clinical Trials 1/10/2017
Trump's Defense Pick Officially Cuts Ties With Theranos 1/10/2017
Troubled Theranos Pink Slips Another 41% of Workforce 1/10/2017
What You Need to Know About Homology Medicines 1/9/2017
What You Need to Know About Fulcrum Therapeutics 1/9/2017
What You Need to Know About Arrivo BioVentures 1/9/2017
What You Need to Know About Pliant 1/9/2017
JPM17: OncoGenex (OGXI) CMO Cindy Jacobs Looks to WIB Boardroom Ready Program to Reach Goal 1/9/2017
JPM17: A First: Women in Bio’s Cynthia Smith Tapped for Nivalis (NVLS) Board 1/9/2017
JPM17: A Year Later, Alison Arter Sees Progress with Women in Bio Boardroom Ready Program 1/9/2017
7 Things the Typical PhD Scientist Doesn’t Know About a Biotech or Pharma Job Search 1/9/2017
Gilead (GILD)'s New Hire Fuels Talk of an Acquisition 1/9/2017
Bay Area Genetic Testing Firm Counsyl Lays Off Oncology Sales Team 1/9/2017
Here’s What You Need to Know About Biotech and Pharma to Land a Job in 2017 1/9/2017
Former Biogen (BIIB) CEO to Helm Newly Launched Bay Area Startup Vir Biotechnology 1/9/2017
JPM17: Boardroom Ready Program Prepares 20 Women for Spots on Biotech Corporate Boards 1/9/2017
JPM17: One Year after ‘The Party,’ Michael Rice, LifeSci Advisors Spearhead Gender Diversity in Life Sciences 1/9/2017
JPM17: Prophase CEO Joins Boardroom Ready Program to Take Next Career Step 1/9/2017
The Next Generation: Top 20 Life Science Startups to Watch in 2017 1/9/2017
Tiny Boston Biotech Pieris Nabs $570 Million+ Cancer Deal With French Powerhouse Servier 1/6/2017
SoCal's Ionis Pharma (IONS) Stock Jolted by $1.6 Billion Cardio Drug Deal With This Big Pharma 1/6/2017
Amgen (AMGN) Shares Soar After Blocking Rivals From Selling Competing Cholesterol-Lowering Drug 1/6/2017
This is Why Actelion (ALIOF.PK) Canceled Its Appearance at the J.P. Morgan Conference Next Week 1/6/2017
5 Biotechs That Could be Big Takeover Targets in 2017 1/6/2017
Rumors Have Pfizer (PFE) Eyeing This SoCal Biotech 1/6/2017
Bay Area's Dynavax (DVAX) Slashes Global Workforce by 38% in Restructuring 1/6/2017
Cambridge's Momenta (MNTA) Jumps on $600 Million R&D Pact With This Global Biotech 1/6/2017
Embattled Theranos Gets a New Landlord 1/6/2017
New Eli Lilly (LLY) CEO's First Move: Shakes Up Leadership Structure in Effort to Recover From Alzheimer's Drug Flop 1/6/2017
Novartis AG (NVS) Athens Offices Raided in Bribery Probe, Exec Threatens With Suicide at Nearby Hotel 1/6/2017
13 Reasons to Watch the J.P. Morgan Healthcare Conference Next Week 1/6/2017
Preparing for a Life Sciences STEM Career? Here Are 5 Ways to Set Yourself Up for Success 1/5/2017
SoCal Biotech Arena (ARNA) Officially Bails on Weight Loss Drug to Focus on New Products 1/5/2017
Alexion (ALXN) Admits Senior Management Pressured Staff to Boost Soliris Sales 1/5/2017
Gilead (GILD) Poaches Cancer R&D Superstar From Novartis AG (NVS) 1/5/2017
How Boston’s Paratek Pharma (PRTK) is Taking Aim at Antibiotic Market and Could Add 85 Jobs 1/5/2017
How to Use These Top 6 Unique Interview Tips to Get Your Next Life Science Job 1/5/2017
Massachusetts Startup Neon Therapeutics Rakes in $70 Million for Personalized Cancer Vaccines 1/5/2017
Listen Up Researchers: Versant Ventures to Fund 2 Dozen Biotech Startups With $400 Million 1/4/2017
Chinese Upstart Ascletis Bags $100 Million in Series B Financing 1/4/2017
3 Quiet Biotechs Ready to Make Some Noise in 2017 1/4/2017
Infinity Pharma (INFI) Promotes a Handful of Execs, Announces Retirement of R&D Head Effective Jan. 6 1/4/2017
A Look Into Billionaire Dr. Phillip Frost's Risky Biotech Portfolio 1/4/2017
Shire (SHPG) Sells RNA Therapy Program to RaNA Therapeutics for Stake in Company 1/4/2017
As Promised, Allergan (AGN) Unveils Single-Digit Price Hikes for 9 Brand Name Drugs 1/4/2017
New Jersey's Braeburn Pharma Files Paperwork for $150 Million IPO 1/4/2017
Novartis AG (NVS) Rumored to Be Buying Intercept Pharma (ICPT) 1/4/2017
7 Juicy Acquisition Targets in Biopharma for 2017 1/4/2017
Nivalis (NVLS) Begins Exploring Strategic Alternatives and Streamlining Ops After Clinical Trial Setback 1/4/2017
1 Bay Area and 1 Massachusetts Biotech That Made Investors Squeal With Glee Last Year 1/4/2017
Top Harvard Scientist Retracts Diabetes Breakthrough Paper 1/4/2017
How Allergan (AGN) CEO's New Model Will be Tested in 2017 1/3/2017
7 Biotech Companies With Key FDA Decisions or Catalysts in January and February 2017 1/3/2017
7 Biotech Stocks to Watch in 2017 1/3/2017
Phase III Flop for Pfizer (PFE)'s Drug Partner Opko Health (OPK) 1/3/2017
Cambridge-Based Jounce Files for $75 Million IPO 1/3/2017
FDA Approval of Aurobindo (AUROPHARMA.BO)'s Two Drugs Sends Stock Up 1/3/2017
Stem Cell Company Cellular Dynamics Expands and Relocates New Headquarters 1/3/2017
4 Fatal Deaths in Seattle Genetics (SGEN)' Early-Stage Trials of AML Drug 12/30/2016
Fortress Biotech (FBIO) Surged After Reporting Big Success With CAR-T Cancer Approach 12/30/2016
Solid as a Rock, RAUMEDIC Continues U.S. Hiring Spree in 2017 12/30/2016
Innocoll (INNL) Shares Tumble After FDA's Refusal to File Xaracoll NDA 12/30/2016
Crown Bioscience Sets Up New U.S. Pharma Subsidiary and Creates Jobs With $70K Salaries 12/30/2016
FDA Rejects Cempra (CEMP)'s NDAs for Solithromycin, Shares Sink 12/30/2016
Like It or Not: Here's How Much Biogen (BIIB)’s Spinraza Will Cost 12/30/2016
Provectus Fires Peter Culpepper as Interim CEO and COO 12/30/2016
Up-and-Coming Tedor Pharma Expands and Adds New Jobs 12/29/2016
Anthera Pharma (ANTH) Plunges After Cystic Fibrosis Drug Fails Late-Stage Trial 12/29/2016
FDA Approves First-Ever Treatment for Spinal Muscular Atrophy; Ionis Pharma (IONS), Biogen (BIIB) Seal Victory 12/29/2016
3 Headwinds AbbVie (ABBV) Faces in 2017 12/29/2016
Investors, Put Your Emotions Aside: There is Hope for Valeant (VRX) in 2017 12/29/2016
3 Worst Performing Pharma Stocks for 2016 12/29/2016
Bay Area Biotech Nabs $50 Million Cash Upfront in Partnership Expansion With Vifor Pharma 12/29/2016
A Turnaround: Regeneron (REGN) Eyes a Comeback in 2017 12/28/2016
Inside Stock Purchases Hint That Abbott (ABT) Deals Will Be Resolved 12/28/2016
Taking a Shot on Who Might Buy Incyte (INCY) in 2017 12/28/2016
SoCal Essentialis and Bay Area Biotech to Merge and Form Newly Combined Company 12/28/2016
Beware: Rapes Alleged at Genentech (RHHBY) by Janitorial Contractor 12/28/2016
The Last Week Of 2016 Could Be Big For These 9 Biotech Catalysts 12/28/2016
The 7 Worst Clinical Disasters of 2016 12/27/2016
California Biotech ChromaDex, Inc. to Set Up New R&D Plant in Longmont 12/27/2016
Hemostemix to Reorganize; Appoints New Board and Executive Team 12/27/2016
After Fraud Probe, Alexion (ALXN) Reports Failed Soliris Trial 12/27/2016
Tolero Pharmaceuticals to Be Acquired for Up to $780 Million 12/27/2016
Massachusetts Biotech OvaScience (OVAS) Slashes 30% of Workforce; CEO and COO Resign 12/27/2016
These 3 Biotech Stocks Are Better Buys Than Gilead (GILD) 12/27/2016
Ophthotech (OPHT) Clinical Disaster Spurs Massive Layoffs 12/27/2016
2017 is Make-or-Break for This Biotech 12/22/2016
Sun Pharma (SUNPHARMA.NS) to Acquire Cancer Product from Novartis AG (NVS) for $175 Million 12/22/2016
Battle for Actelion (ALIOF.PK): Sanofi (SNY) is Out, Johnson & Johnson (JNJ) is Back In 12/22/2016
Sinovac Biotech Ltd. (SVA) CEO Reportedly Bribed Chinese FDA, Buyout Offers Could Be in Jeopardy 12/22/2016
Introducing the Newly Formed OticPharma 12/22/2016
This is Why Biogen (BIIB)’s Stock is Set to Soar in 2017 12/22/2016
Roche (RHHBY) Takes a Win as Emicizumab Hemophilia Drug Succeeds in Phase III 12/22/2016
This Biotech Forges $200+ Million Research Pact With Incyte (INCY) 12/22/2016
Merrimack (MACK) Halts Phase II HERMIONE Study for Breast Cancer; Further Plans Revealed in January 12/22/2016
Bay Area’s CBT Pharma Plans to Launch 2 Phase I Trials in 2017 12/22/2016
Meet Biogen (BIIB)'s New CEO 12/21/2016
Investors Grow Impatient With Sanofi (SNY) and Actelion (ALIOF.PK) Over Acquisition and Possible Contingent Value Right 12/21/2016
Former Sanofi (SNY) and Lupin Pharmaceuticals, Inc. Execs Jump to Endo International (ENDP) 12/21/2016
Acadia (ACAD) Stock Screams Upward; Primary Endpoint Met in Phase II Study of Pimavanserin for Alzheimer’s 12/21/2016
Allergan (AGN) Dives Deep into $2.9 Billion Cash Deal With New Jersey Biotech 12/21/2016
Effective Immediately: Bay Area IMPAX Labs (IPXL) Seeks New CEO 12/21/2016
Launched in 2015 with $45 Million, Bay Area Revolution Medicines Scores $25 Million 12/21/2016
3 Cheap Biotech Stocks Ready to Rock 12/21/2016
Why This Biotech Stock Should Be on Everyone's Christmas List 12/21/2016
Newly Formed Company Established by Pluristem Therapeutics (PSTI) and Sosei CVC 12/20/2016
5 Life Science Stocks Are Breaking Out This Christmas 12/20/2016



//-->